Safety and Efficacy of MBI 226 1.25% and 2.5% Topical Acne Solutions in the Treatment of Acne
Clinical trial NCT00211497 · COMPLETED
Trial details
- NCT number
- NCT00211497
- Sponsor
- BioWest Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.